Status:
UNKNOWN
Noninvasive Preimplantation Genetic Testing for Aneuploidy
Lead Sponsor:
Mỹ Đức Hospital
Collaborating Sponsors:
My Duc Phu Nhuan Hospital
Conditions:
Preimplantation Genetic Testing (PGT)
ICSI
Eligibility:
All Genders
Brief Summary
The study is conducted to evaluate the sensitivity and specificity of non-invasive preimplantation genetic testing for aneuploidy (NiPGT-A) using cell free DNA into spent culture medium (SCM).
Detailed Description
Our study is a diagnostic study, recruit 218 biopsied blastocysts from couples undergoing intracytoplasmic sperm injection (ICSI) with Preimplantation genetic testing for aneuploidy (PGT-A) or Preimpl...
Eligibility Criteria
Inclusion
- Assisted Reproductive Treatment with ICSI indication
- Having PGT-A or PGT-SR indication
- Having an agreement to be enrolled into NiPGT-A study
- Having blastocyst to biopsy
Exclusion
- In vitro maturation cycle
Key Trial Info
Start Date :
August 15 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 30 2020
Estimated Enrollment :
218 Patients enrolled
Trial Details
Trial ID
NCT04490889
Start Date
August 15 2020
End Date
November 30 2020
Last Update
September 22 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
My Duc Phu Nhuan Hospital
Ho Chi Minh City, Phu Nhuan, Vietnam
2
My Duc Hospital
Ho Chi Minh City, Vietnam